Most likely, the way people have stopped looking askance at Botox, fillers and lip jobs, GLPs will go mainstream too. In a world where maintaining an image is critical, whatever enhancements we make or don’t make, many of us will continue to feel that we need…
The patent of the blockbuster diabetes and weight loss drug semaglutide expires this weekend. Pharma majors like Cipla and Zydus plan to launch their generic versions in India at a fraction of their … [+3694 chars]
